Feng Luo
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 20
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 6
- Colorectal Cancer Treatments and Studies 5
-
- Wnt/β-catenin signaling in development and cancer 4
- Cancer-related gene regulation 3
- Co-authors
- Stephen G. Chaney (5 shared papers)Steven D. Wyrick (4 shared papers)Jinbang Li (5 shared papers)Kunping Liu (4 shared papers)Jean Lu (3 shared papers)Patrick J. Sinko (2 shared papers)Ailan Guo (2 shared papers)Eric H. Rubin (2 shared papers)
- Journals
- Clinical Cancer Research (4 papers)Cancer Chemotherapy and Pharmacology (4 papers)Scientific Reports (2 papers)International Journal of Oncology (2 papers)Alzheimer s & Dementia (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Feng Luo
36 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 101
- Oncology 552
- Reproductive Medicine 150
- Hematology 175
- Genetics 129
- Molecular Biology 496
Countries citing papers authored by Feng Luo
This map shows the geographic impact of Feng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Luo more than expected).
Fields of papers citing papers by Feng Luo
This network shows the impact of papers produced by Feng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Luo. The network helps show where Feng Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 125 | |
| 2 | 2006 | 113 | |
| 3 | 2016 | 88 | |
| 4 | 2002 | 86 | |
| 5 | 2009 | 85 | |
| 6 | 2005 | 66 | |
| 7 | 2006 | 65 | |
| 8 | 2005 | 59 | |
| 9 | 1999 | 56 | |
| 10 | 2002 | 55 | |
| 11 | 2004 | 54 | |
| 12 | 2001 | 49 | |
| 13 | 2008 | 43 | |
| 14 | 1999 | 41 | |
| 15 | 1999 | 38 | |
| 16 | 1999 | 29 | |
| 17 | Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity. | 2002 | 27 |
| 18 | 2019 | 25 | |
| 19 | 2020 | 23 | |
| 20 | 2014 | 23 |
About Feng Luo
Feng Luo is a scholar working on Oncology, Molecular Biology, Genetics, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Alzheimer's disease research and treatments (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Eosinophilic Disorders and Syndromes (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Oncology (552 citations), Reproductive Medicine (150 citations), Hematology (175 citations), Genetics (129 citations) and Molecular Biology (496 citations). Feng Luo has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Stephen G. Chaney, Steven D. Wyrick, Jinbang Li, Kunping Liu, Jean Lu, Patrick J. Sinko, Ailan Guo, Eric H. Rubin, Wenxin Zheng and Anne Blackwood‐Chirchir. Their work appears in journals such as Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, Scientific Reports, International Journal of Oncology and Alzheimer s & Dementia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.